- Home
- BHVN vs ACHC Comparison
BHVN vs ACHC Comparison
Compare BHVN & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- ACHC
- Stock Information
- Founded
- BHVN 2013
- ACHC 2005
- Country
- BHVN United States
- ACHC United States
- Employees
- BHVN N/A
- ACHC N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- ACHC Medical Specialities
- Sector
- BHVN Health Care
- ACHC Health Care
- Exchange
- BHVN Nasdaq
- ACHC Nasdaq
- Market Cap
- BHVN 1.5B
- ACHC 1.7B
- IPO Year
- BHVN 2017
- ACHC N/A
- Fundamental
- Price
- BHVN $13.85
- ACHC $21.83
- Analyst Decision
- BHVN Strong Buy
- ACHC Buy
- Analyst Count
- BHVN 15
- ACHC 11
- Target Price
- BHVN $56.07
- ACHC $41.23
- AVG Volume (30 Days)
- BHVN 2.1M
- ACHC 2.4M
- Earning Date
- BHVN 11-11-2025
- ACHC 10-29-2025
- Dividend Yield
- BHVN N/A
- ACHC N/A
- EPS Growth
- BHVN N/A
- ACHC N/A
- EPS
- BHVN N/A
- ACHC 1.52
- Revenue
- BHVN N/A
- ACHC $3,229,609,000.00
- Revenue This Year
- BHVN N/A
- ACHC $7.48
- Revenue Next Year
- BHVN $2,002.87
- ACHC $7.40
- P/E Ratio
- BHVN N/A
- ACHC $14.69
- Revenue Growth
- BHVN N/A
- ACHC 5.64
- 52 Week Low
- BHVN $12.79
- ACHC $17.13
- 52 Week High
- BHVN $55.70
- ACHC $79.83
- Technical
- Relative Strength Index (RSI)
- BHVN 40.24
- ACHC 48.12
- Support Level
- BHVN $13.63
- ACHC $20.91
- Resistance Level
- BHVN $17.05
- ACHC $24.42
- Average True Range (ATR)
- BHVN 0.87
- ACHC 1.01
- MACD
- BHVN -0.23
- ACHC -0.08
- Stochastic Oscillator
- BHVN 4.42
- ACHC 25.93
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.